Intelligent Bio Solutions EBIT 2020-2025 | INBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Intelligent Bio Solutions ebit from 2020 to 2025. Ebit can be defined as earnings before interest and taxes.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Intelligent Bio Solutions ebit from 2020 to 2025. Ebit can be defined as earnings before interest and taxes.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$150.5B
CVS Health (CVS)	$84.6B
Elevance Health (ELV)	$66.5B
Cencora (COR)	$57.2B
DiDi Global (DIDIY)	$25.8B
Labcorp Holdings (LH)	$22.5B
Natera (NTRA)	$21.7B
BioMerieux (BMXMF)	$17.2B
EUROFINS SCIENT (ERFSF)	$15.5B
ICON (ICLR)	$14.2B
CochLear (CHEOY)	$13B
Medpace Holdings (MEDP)	$12.9B
Solventum (SOLV)	$12.7B
Viatris (VTRS)	$12.5B
Caris Life Sciences,�Inc (CAI)	$10.4B
Revvity (RVTY)	$10.4B
Sonic Healthcare (SKHHY)	$9.2B
Avantor (AVTR)	$8.8B
Charles River Laboratories (CRL)	$7.7B
HealthEquity (HQY)	$7.6B
Bausch + Lomb (BLCO)	$5B
Sotera Health (SHC)	$4.5B
BrightSpring Health Services (BTSG)	$4B
Amplifon S.p.A (AMFPF)	$3.9B
GeneDx Holdings (WGS)	$3.5B
Concentras Parent (CON)	$3B
Alignment Healthcare (ALHC)	$2.9B
Surgery Partners (SGRY)	$2.9B
Organon (OGN)	$2.4B
Premier (PINC)	$2B